ANTX vs GILD: Which Stock is Better?
Side-by-side comparison of An2 Therapeutics Inc and Gilead Sciences Inc in 2026
ANTX
An2 Therapeutics Inc
$2.85
GILD
Gilead Sciences Inc
$143.93
Key Metrics Comparison
| Metric | ANTX | GILD | Winner |
|---|---|---|---|
| Market Cap | $46.86M | $180.18B | GILD |
| P/E Ratio | N/A | 21.41 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze ANTX
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANTX or GILD a better investment?
Comparing ANTX and GILD: An2 Therapeutics Inc has a market cap of $46.86M while Gilead Sciences Inc has $180.18B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANTX and GILD?
ANTX (An2 Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANTX or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANTX or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for ANTX.
Which company is more profitable: ANTX or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for ANTX.
Which is the larger company: ANTX or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $180.18B compared to $46.86M for ANTX.
Should I buy ANTX or GILD in 2026?
Both ANTX and GILD have investment merit. ANTX trades at $2.85 while GILD trades at $143.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANTX and GILD stock?
Key differences: Market Cap ($46.86M vs $180.18B), P/E Ratio (N/A vs 21.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).